MDA vs WSC

MDA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational efficiency. The stock is trading at a significant premium, with a current price of $29.10 far exceeding both the Graham Number ($10.37) and the growth-based Intrinsic Value ($5.64). While recent Q/Q revenue growth of 44% shows short-term momentum, the stagnant YoY revenue growth (0.20%) and thin profit margins (2.24%) fail to justify the high P/E ratio of 46.94. The combination of a bearish technical trend and poor deterministic scores suggests a high risk of price correction.

WSC exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. The company is burdened by excessive leverage (Debt/Equity of 4.56) and liquidity constraints (Current Ratio of 0.86), which are compounded by negative net profit margins and declining revenue growth (-6.10% YoY). Despite a recent short-term price spike and a 'Buy' consensus from analysts, the company has missed earnings estimates in 4 consecutive quarters with an average surprise of -17.02%. The disconnect between analyst optimism and the deterministic health scores suggests a high-risk profile.